Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aeromedic Innovations was a medical technology firm based in the United Kingdom, primarily known for its rapid response to the clinical safety needs of the COVID-19 pandemic. The company developed the Aerosol Shield, a transparent, foldable, and disposable barrier designed to protect healthcare workers from aerosolized pathogens during critical procedures like intubation and extubation. Founded by a team of clinicians, including intensive care specialists, the company focused on practical, evidence-based solutions for high-risk medical environments. Their products were adopted by numerous hospitals globally to mitigate the risk of viral transmission to frontline staff. Although the company was dissolved in 2022, its work represented a significant contribution to personal protective equipment (PPE) innovation during a global health crisis. The firm's legacy continues through the widespread clinical adoption of aerosol containment strategies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aeromedic Innovations.